168 related articles for article (PubMed ID: 22378696)
1. Levetiracetam for busulfan-induced seizure prophylaxis in children undergoing hematopoietic stem cell transplantation.
Soni S; Skeens M; Termuhlen AM; Bajwa RP; Gross TG; Pai V
Pediatr Blood Cancer; 2012 Oct; 59(4):762-4. PubMed ID: 22378696
[TBL] [Abstract][Full Text] [Related]
2. Levetiracetam for the prevention of busulfan-induced seizures in pediatric hematopoietic cell transplantation recipients.
Floeter AE; McCune JS
J Oncol Pharm Pract; 2017 Jul; 23(5):344-349. PubMed ID: 27208016
[TBL] [Abstract][Full Text] [Related]
3. Comparison of levetiracetam versus phenytoin/fosphenytoin for busulfan seizure prophylaxis at a pediatric institution.
Hughes K; Garrity L; Nelson AS; Lane A; Teusink-Cross A
Pediatr Transplant; 2021 Jun; 25(4):e14026. PubMed ID: 33894096
[TBL] [Abstract][Full Text] [Related]
4. Busulfan triggers epileptic seizures under levetiracetam and valproic acid therapy.
Yazal Erdem A; Azık F; Tavil B; Teber S; Tunç B; Uçkan D
Pediatr Transplant; 2014 Jun; 18(4):412-3. PubMed ID: 24645650
[No Abstract] [Full Text] [Related]
5. Optimal prevention of seizures induced by high-dose busulfan.
Eberly AL; Anderson GD; Bubalo JS; McCune JS
Pharmacotherapy; 2008 Dec; 28(12):1502-10. PubMed ID: 19025431
[TBL] [Abstract][Full Text] [Related]
6. Pretransplant conditioning in adults and children: dose assurance with intravenous busulfan.
Fisher VL; Barnes YJ; Nuss SL
Oncol Nurs Forum; 2006 Nov; 33(2):E36-43. PubMed ID: 16518436
[TBL] [Abstract][Full Text] [Related]
7. Comparison of levetiracetam with phenytoin for the prevention of intravenous busulfan-induced seizures in hematopoietic cell transplantation recipients.
Akiyama K; Kume T; Fukaya M; Shiki I; Enami T; Tatara R; Shino M; Ikeda T
Cancer Chemother Pharmacol; 2018 Oct; 82(4):717-721. PubMed ID: 30083882
[TBL] [Abstract][Full Text] [Related]
8. Cost-utility analysis of levetiracetam and phenytoin for posttraumatic seizure prophylaxis.
Cotton BA; Kao LS; Kozar R; Holcomb JB
J Trauma; 2011 Aug; 71(2):375-9. PubMed ID: 21825941
[TBL] [Abstract][Full Text] [Related]
9. Oral lorazepam prevents seizure during high-dose busulfan in children undergoing hematopoietic stem cell transplantation: a prospective study.
Hamidieh AA; Hamedani R; Hadjibabaie M; Amini M; Sadrai S; Ghavamzadeh A
Pediatr Hematol Oncol; 2010 Oct; 27(7):529-33. PubMed ID: 20677921
[TBL] [Abstract][Full Text] [Related]
10. Comparison of clonazepam and levetiracetam in children for prevention of busulfan-induced seizure in hematopoietic stem cell transplantation.
Tsujimoto SI; Shirai R; Utano T; Osumi T; Matsumoto K; Shioda Y; Kiyotani C; Uchiyama T; Deguchi T; Terashima K; Tomizawa D; Matsumoto K; Kato M
Int J Hematol; 2020 Mar; 111(3):463-466. PubMed ID: 31863341
[TBL] [Abstract][Full Text] [Related]
11. Lorazepam for seizure prophylaxis during high-dose busulfan administration.
Chan KW; Mullen CA; Worth LL; Choroszy M; Koontz S; Tran H; Slopis J
Bone Marrow Transplant; 2002 Jun; 29(12):963-5. PubMed ID: 12098063
[TBL] [Abstract][Full Text] [Related]
12. Comparison of valproate and levetiracetam for the prevention of busulfan-induced seizures in hematopoietic stem cell transplantation.
Nakashima T; Tanaka T; Koido K; Nishibuchi Y; Hashimoto H; Ito A; Inamoto Y; Kurosawa S; Kim SW; Fukuda T; Terakado H
Int J Hematol; 2019 Jun; 109(6):694-699. PubMed ID: 30915718
[TBL] [Abstract][Full Text] [Related]
13. Outdated dogma? Busulfan, seizure prophylaxis, and stem cell allografting.
Ruiz-Argüelles GJ; Gomez-Almaguer D; Steensma DP
Am J Hematol; 2012 Sep; 87(9):941. PubMed ID: 22674687
[No Abstract] [Full Text] [Related]
14. Levetiracetam versus (fos)phenytoin for seizure prophylaxis in pediatric patients with intracranial hemorrhage.
Bansal S; Blalock D; Kebede T; Dean NP; Carpenter JL
J Neurosurg Pediatr; 2014 Feb; 13(2):209-15. PubMed ID: 24286154
[TBL] [Abstract][Full Text] [Related]
15. Oral levetiracetam for prevention of busulfan-induced seizures in adult hematopoietic cell transplant.
Chaguaceda C; Aguilera-Jiménez V; Gutierrez G; Roura J; Riu G
Int J Clin Pharm; 2020 Apr; 42(2):351-354. PubMed ID: 32026356
[TBL] [Abstract][Full Text] [Related]
16. Levetiracetam Prophylaxis for Post-traumatic Brain Injury Seizures is Ineffective: A Propensity Score Analysis.
Zangbar B; Khalil M; Gruessner A; Joseph B; Friese R; Kulvatunyou N; Wynne J; Latifi R; Rhee P; O'Keeffe T
World J Surg; 2016 Nov; 40(11):2667-2672. PubMed ID: 27307089
[TBL] [Abstract][Full Text] [Related]
17. Levetiracetam for seizures after liver transplantation.
Glass GA; Stankiewicz J; Mithoefer A; Freeman R; Bergethon PR
Neurology; 2005 Mar; 64(6):1084-5. PubMed ID: 15781837
[TBL] [Abstract][Full Text] [Related]
18. Once-daily intravenous busulfan with therapeutic drug monitoring compared to conventional oral busulfan improves survival and engraftment in children undergoing allogeneic stem cell transplantation.
Bartelink IH; Bredius RG; Ververs TT; Raphael MF; van Kesteren C; Bierings M; Rademaker CM; den Hartigh J; Uiterwaal CS; Zwaveling J; Boelens JJ
Biol Blood Marrow Transplant; 2008 Jan; 14(1):88-98. PubMed ID: 18158965
[TBL] [Abstract][Full Text] [Related]
19. Influence on Busilvex pharmacokinetics of clonazepam compared to previous phenytoin historical data.
Carreras E; Cahn JY; Puozzo C; Kröger N; Sanz G; Buzyn A; Bacigalupo A; Vernant JP
Anticancer Res; 2010 Jul; 30(7):2977-84. PubMed ID: 20683042
[TBL] [Abstract][Full Text] [Related]
20. Continuous intravenous infusion of lorazepam as seizure prophylaxis in children treated with high-dose busulfan.
Caselli D; Ziino O; Bartoli A; Santangelo G; Vanadia F; Aricò M
Bone Marrow Transplant; 2008 Jul; 42(2):135-6. PubMed ID: 18372906
[No Abstract] [Full Text] [Related]
[Next] [New Search]
